Trastuzumab containing regimens for metastatic breast cancer

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

1. To evaluate the efficacy of trastuzumab (a monoclonal antibody against HER2) alone or in combination with other drug therapy in women with metastatic breast cancer.
2. To evaluate the toxicity of trastuzumab alone or in combination with other drug therapy in women with metastatic breast cancer.